Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Posts Tagged ‘NASDAQ:ALIM’
Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
In this article we will take a look at whether hedge funds think Alimera Sciences Inc (NASDAQ:ALIM) is a good investment right now. We check hedge fund...
Did Hedge Funds Drop The Ball On Alimera Sciences Inc (ALIM) ?
“The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among...
13G Filing: Palo Alto Investors and Alimera Sciences Inc (ALIM)
Alimera Sciences Inc (NASDAQ:ALIM): William Leland Edwards’ Palo Alto Investors filed an amended 13D. You can check out Palo Alto Investors’...
13D Filing: Intersouth Partners VI LP and Alimera Sciences Inc (ALIM)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 19 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Is Alimera Sciences Inc (ALIM) A Good Stock To Buy?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined...
Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake
Jeffrey Jay and David Kroin‘s Great Point Partners reported the acquisition of 3.25 million common shares of Alimera Sciences Inc (NASDAQ:ALIM)...
Tempur Sealy (TPX), GrubHub (GRUB), United States Steel Corporation (X) Among Top Weekly Gainers
It was a mixed week for the market last week, as the Dow gave up 0.75% of its value, while the S&P 500 was down slightly, and the Nasdaq was 1.21%...
Tiger Global Cuts Stake in Autohome, While Deerfield Buys More Shares of This Pharmaceutical Company
Federal funds future contracts suggest a 79% probability that the Federal Reserve will raise interest rates at the December policy meeting, an event which...
Three Healthcare Stocks Hedge Funds Are Snapping Up
Is it a good time to buy Alimera Sciences Inc (NASDAQ:ALIM)? James E. Flynn thinks so, having recently acquired 321,784 shares of the pharmaceutical...
Jeffrey Ray’s Great Point Partners Trims Its Stake In Alcobra Ltd (ADHD)
Jeffrey Jay and David Kroin’s healthcare-focused fund, Great Point Partners, decreased its passive stake in the Israel based biopharmaceutical...
Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners
Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund...
Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E. Flynn’s Deerfield Management and...
Alimera Sciences Inc (ALIM) & Bio Blast Pharma Ltd (ORPN): 2 Pharmaceutical Stocks Hedge Funds are Increasing Their Stakes In
Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in. However, it’s the sector-specific...
VIRGINIA NATL BNK (VABK), Alimera Sciences Inc (ALIM), Advanced Photonix, Inc. (API): Hedge Funds Disclose Moves In Their Equity Portfolios
Tim Mullen and his fund, Swift Run Capital Management, have sent a presentation to the management of VIRGINIA NATL BNK (OTCMKTS:VABK), in which they...
